SK6492002A3 - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer Download PDF

Info

Publication number
SK6492002A3
SK6492002A3 SK649-2002A SK6492002A SK6492002A3 SK 6492002 A3 SK6492002 A3 SK 6492002A3 SK 6492002 A SK6492002 A SK 6492002A SK 6492002 A3 SK6492002 A3 SK 6492002A3
Authority
SK
Slovakia
Prior art keywords
ethyl
phenoxy
propoxy
mmol
formula
Prior art date
Application number
SK649-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Jerome Herbert Fleisch
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Douglas Wade Beight
Edward C R Smith
William Thomas Mcmillen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SK6492002A3 publication Critical patent/SK6492002A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SK649-2002A 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer SK6492002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
SK6492002A3 true SK6492002A3 (en) 2003-09-11

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
SK649-2002A SK6492002A3 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Country Status (22)

Country Link
EP (1) EP1231938A2 (es)
JP (1) JP2003513916A (es)
KR (1) KR20020069512A (es)
CN (1) CN1390139A (es)
AR (1) AR032432A1 (es)
AU (1) AU778829B2 (es)
BR (1) BR0015490A (es)
CA (1) CA2391416A1 (es)
CZ (1) CZ20021551A3 (es)
EA (1) EA200200545A1 (es)
HK (1) HK1050132A1 (es)
HU (1) HUP0204449A3 (es)
IL (1) IL148579A0 (es)
MX (1) MXPA02004733A (es)
NO (1) NO20022245L (es)
NZ (1) NZ517667A (es)
PE (1) PE20010701A1 (es)
PL (1) PL355172A1 (es)
SK (1) SK6492002A3 (es)
TR (1) TR200201245T2 (es)
WO (1) WO2001034137A2 (es)
ZA (1) ZA200202822B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
CA2408622A1 (en) * 2000-05-09 2001-11-15 Creighton University Methods for inhibiting proliferation and inducing apoptosis in cancer cells
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
WO2005105736A1 (en) 2004-05-05 2005-11-10 Novo Nordisk A/S Novel compounds, their preparation and use
ES2352085T3 (es) 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
ATE529404T1 (de) 2005-06-30 2011-11-15 High Point Pharmaceuticals Llc Phenoxyessigsäuren als ppar-delta-aktivatoren
EP1979311B1 (en) 2005-12-22 2012-06-13 High Point Pharmaceuticals, LLC Phenoxy acetic acids as ppar delta activators
CA2645719A1 (en) 2006-03-09 2007-09-13 High Point Pharmaceuticals, Llc Compounds that modulate ppar activity, their preparation and use
AU2007307597A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
EP2914587A1 (de) 2012-10-31 2015-09-09 Bayer CropScience AG Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
CN1390139A (zh) 2003-01-08
PL355172A1 (en) 2004-04-05
BR0015490A (pt) 2002-07-09
CZ20021551A3 (cs) 2003-02-12
NO20022245L (no) 2002-07-09
NO20022245D0 (no) 2002-05-10
ZA200202822B (en) 2003-09-23
HUP0204449A2 (hu) 2003-04-28
PE20010701A1 (es) 2001-07-07
TR200201245T2 (tr) 2004-08-23
AU1599001A (en) 2001-06-06
KR20020069512A (ko) 2002-09-04
AR032432A1 (es) 2003-11-12
WO2001034137A2 (en) 2001-05-17
EP1231938A2 (en) 2002-08-21
WO2001034137A3 (en) 2002-02-14
HUP0204449A3 (en) 2006-02-28
IL148579A0 (en) 2002-09-12
CA2391416A1 (en) 2001-05-17
MXPA02004733A (es) 2002-08-30
JP2003513916A (ja) 2003-04-15
AU778829B2 (en) 2004-12-23
HK1050132A1 (zh) 2003-06-13
NZ517667A (en) 2004-05-28
EA200200545A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
SK6492002A3 (en) Oncolytic combinations for the treatment of cancer
JP5984808B2 (ja) C−アリールグルコシド誘導体、製造法およびその医薬用途
TWI331034B (en) Inhibitors of cyclin-dependent kinases and their use
US9062087B2 (en) Phenyl C-glucoside derivatives, preparation methods and uses thereof
RU2160257C2 (ru) Способ получения фенильных гетероциклов и промежуточное соединение
ES2397664T3 (es) Derivados de glucopiranósilo que contienen tienilo como antidiabéticos
CN101503399B (zh) C-芳基葡萄糖苷sglt2抑制剂
JP2015003909A (ja) ベンゾピラン化合物の組合せ、その組成物および使用
KR20100137551A (ko) 벤조피란 및 벤족세핀 pi3k 저해제 화합물 및 이의 사용 방법
EA024368B1 (ru) Процесс получения соединений для применения в качестве ингибиторов sglt2
US4551282A (en) Triphenylene derivatives
EA021983B1 (ru) Производные диоксабицикло[3.2.1]октан-2,3,4-триола
US9012412B2 (en) Dual SGLT1/SGLT2 inhibitors
WO2014094544A1 (zh) 含脱氧葡萄糖结构的苯基c-葡萄糖苷衍生物及其制备方法和用途
CN114149423A (zh) 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
AU2041801A (en) Oncolytic combinations for the treatment of cancer
WO2005079803A1 (en) Compounds for treatment of cardiovascular diseases
WO2001034197A2 (en) Oncolytic combinations for the treatment of cancer
ES2309340T3 (es) Abridor del canal de k activado por calcio de alta conductancia.
BR112021013348A2 (pt) Composto de fórmula geral, um isômero óptico, uma forma cristalina, um sal farmaceuticamente aceitável, um hidrato ou um solvato do mesmo; composto ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica de combinação e uso do composto
JP5339041B2 (ja) 新規ナフトキノン化合物およびその医薬用途
KR101360579B1 (ko) 신규 페닐초산 유도체
MXPA02004646A (es) Antagonistas de leucotrieno de difenilo substituido con heterociclo.
TWI510491B (zh) C-芳基葡萄糖苷衍生物、其製備方法及其在醫藥上的應用

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure